vaccines Flashcards
HBV Routine immunization of infants– 3 doses ?
Birth, 1 month, 6 months
HBV Routine immunization for adolescents ?
3 doses of pediatric or
2 doses of adult
Pediatric HBV ?
Recombivax or Engerix 0.5 ml IM
Adult HBV ?
Recombivax 1 ml IM
RV5 ?
Rotateq
RV5 doses ?
latex-free, no reconstitution needed, 3 dose series
RV1 ?
Rotarix
RV1 doses ?
has latex, must be reconstituted with diluent, possible increase risk of intussusception, 2 dose series
RV1 months ?
oral
2 and 4
RV5 months ?
oral
2 4 6
Rotavirus, dont start if ?
Do not start if 15 weeks or older
If infant spits it up, do not repeat dose
DTaP marketed as ?
Daptacel, Infanrix, Tripedia
DTaP amount ?
0.5 mL IM
DTaP months ?
2, 4, 6 and 15-18 months, and 4-6 years (5 doses)
5 doses
3 months – not adequately immunized
DT ?
when pertussis is contraindicated
Td ?
tetanus toxoid and reduced amount of diphtheria, typically for adults requiring tetanus
DtaP-Hib ?
(TriHIBit),
DTaP-IPV-HepB ?
(Pedarix),
DTaP-IPV-Hib ?
(Pentacel),
DTaP-IPV ?
(Kinrix)
DTaP contraindications ?
Anaphylactic-type reaction to previous dose
Encephalopathy within 7 days of previous dose (not attributable to another cause)
Progressive neurologic d/o
DTaP precautions ?
High fever (40.5C)
Persistent, inconsolable crying within 48⁰ of previous dose
Seizures within 3 days of previous dose
DTaP AR ?
Local reaction, especially with increasing number of doses
Fever
PedvaxHIB months ?
2, 4, and 12-15 mos
H. flu only
ActHIB months ?
2, 4, 6 and 12-15 mos
H. fu only
Pneumococcal conjugate vaccine (PCV13) recommendation ?
all children younger than 5 years old, all adults 65 years or older, and people 6 years or older withcertain risk factors.
Pneumococcal polysaccharide vaccine (PPSV23) recommendation ?
all adults 65 years or older. People 2 through 64 years old who are athigh risk of pneumococcal diseaseshould also receive PPSV23.
PCV13: Age at 1st dose (months): 2-6 months ?
3 doses
1 dose at 12-15 mos booster
PCV13: Age at 1st dose (months) 7-11 months ?
2 doses
1 dose at 12-15 mos booster
PCV13: Age at 1st dose (months) 12-23 months ?
2 doses
no booster
PCV13: Age at 1st dose (months) 24-59 months in healthy children ?
1 dose
no booster
PCV13: Age at 1st dose (months) 24-71 months in children at risk* ?
2 doses
no booster